⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Sarah BaldwinANP

Nurse Practitioner · Houston, TX 77030

NPI: 1972810257

Share:

48

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers99th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

78

Total Claims

$3,695

Drug Cost

60

Beneficiaries

$62

Cost/Patient

Risk Score Breakdown 48/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+15
Long-acting opioid rate+8

Score components are additive. Read full methodology

Peer Comparison vs. 218,535 Nurse Practitioner providers

+2273%

Opioid rate vs peers

89.7% vs 3.8% avg

-95%

Cost per patient vs peers

$62 vs $1,174 avg

+305%

Brand preference vs peers

35.9% vs 8.9% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 2,273% above the average for Nurse Practitioner providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

89.7%

Opioid Rate

70

Opioid Claims

$3,436

Opioid Cost

27.1%

Long-Acting Rate

This provider's opioid prescribing rate of 89.7% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

64% generic

Brand: 28 claims · $2,005

Generic: 50 claims · $1,690

Patient Profile

69

Avg Age

45%

Female

2.81

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data